SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 19.92
-0.53 (-2.59%)
Sep 2, 2026, 5:29 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 1.15 billion as of September 2, 2026. Its market cap has increased by 20.64% in one year.
Market Cap
1.15B
Enterprise Value
1.13B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
19.92
ChartMarket Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 1.15B, an increase of 1,696.28%. That is a compound annual growth rate of 32.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 1.15B | -4.99% |
| Dec 30, 2025 | 1.21B | 189.20% |
| Dec 30, 2024 | 416.76M | 32.69% |
| Dec 29, 2023 | 314.09M | -87.00% |
| Dec 30, 2022 | 2.42B | -34.75% |
| Dec 30, 2021 | 3.70B | 242.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 1.58B |
| Flerie AB | 1.56B |
| BioInvent International AB | 1.50B |
| Genovis AB (publ.) | 1.49B |
| Medivir AB | 1.21B |
| AlzeCure Pharma AB | 1.02B |
| Infant Bacterial Therapeutics AB | 863.52M |
| Oncopeptides AB | 755.00M |